Sorrento Therapeutics, Inc. announced the unexpected passing of Mr. Najjam Asghar, Chief Financial Officer. Mr. Asghar died of apparent natural causes on January 6, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0095 USD | 0.00% | 0.00% | -92.31% |
Apr. 10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
1st Jan change | Capi. | |
---|---|---|
-92.31% | 5.17M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- SRNE Stock
- News Sorrento Therapeutics, Inc.
- Sorrento Therapeutics, Inc. Announces Demise of Najjam Asghar, Chief Financial Officer